| Robert M Fields, DO | |
|
5301 Mcauley Dr, Ypsilanti, MI 48197-1051 | |
| (734) 712-3456 | |
| Not Available |
| Full Name | Robert M Fields |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 26 Years |
| Location | 5301 Mcauley Dr, Ypsilanti, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154358463 | NPI | - | NPPES |
| 4668518 | Medicaid | MI | |
| 4668536 | Medicaid | MI | |
| RF013782 | Other | MI | BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 013782 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Mercy Chelsea | Chelsea, MI | Hospital |
| St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospitalist Physicians Medical Group Of Michigan, Pc | 4688778228 | 19 |
News Archive
QRxPharma Limited announced today the United States Food and Drug Administration has scheduled a meeting on 3 October to discuss the Company's MOXDUO New Drug Application for the treatment of moderate to severe acute pain.
Can estrogen preserve brain function and decrease the risk of Alzheimer's disease when given early in menopause? Newly postmenopausal women who received estrogen via a skin patch had reduced beta-amyloid deposits, the sticky plaques found in the brains of people with Alzheimer's disease, a Mayo Clinic study published this month in the Journal of Alzheimer's Disease found.
Taller individuals are more likely to develop cancer than shorter people, according to the results of a study presented at the 54th Annual European Society for Pediatric Endocrinology Meeting in Barcelona.
The budget is not realistic, counting on fantastical revenue projections as well as a redevelopment gambit that's likely to be blocked in court. It makes deep cuts in state programs that will have unwelcome repercussions in years to come. And if the revenue projections prove to be as overly optimistic as they seem, there will be more damaging cuts to education, child care and health services. Nevertheless, it's a more earnest effort to clean up the state's budget mess than Sacramento has seen in a decade or more.
After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.
› Verified 8 days ago
| Entity Name | Chelsea Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912947409 PECOS PAC ID: 0648171074 Enrollment ID: O20040119000004 |
News Archive
QRxPharma Limited announced today the United States Food and Drug Administration has scheduled a meeting on 3 October to discuss the Company's MOXDUO New Drug Application for the treatment of moderate to severe acute pain.
Can estrogen preserve brain function and decrease the risk of Alzheimer's disease when given early in menopause? Newly postmenopausal women who received estrogen via a skin patch had reduced beta-amyloid deposits, the sticky plaques found in the brains of people with Alzheimer's disease, a Mayo Clinic study published this month in the Journal of Alzheimer's Disease found.
Taller individuals are more likely to develop cancer than shorter people, according to the results of a study presented at the 54th Annual European Society for Pediatric Endocrinology Meeting in Barcelona.
The budget is not realistic, counting on fantastical revenue projections as well as a redevelopment gambit that's likely to be blocked in court. It makes deep cuts in state programs that will have unwelcome repercussions in years to come. And if the revenue projections prove to be as overly optimistic as they seem, there will be more damaging cuts to education, child care and health services. Nevertheless, it's a more earnest effort to clean up the state's budget mess than Sacramento has seen in a decade or more.
After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.
› Verified 8 days ago
| Entity Name | Epmg Of Michigan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386688992 PECOS PAC ID: 4789596339 Enrollment ID: O20040211000686 |
News Archive
QRxPharma Limited announced today the United States Food and Drug Administration has scheduled a meeting on 3 October to discuss the Company's MOXDUO New Drug Application for the treatment of moderate to severe acute pain.
Can estrogen preserve brain function and decrease the risk of Alzheimer's disease when given early in menopause? Newly postmenopausal women who received estrogen via a skin patch had reduced beta-amyloid deposits, the sticky plaques found in the brains of people with Alzheimer's disease, a Mayo Clinic study published this month in the Journal of Alzheimer's Disease found.
Taller individuals are more likely to develop cancer than shorter people, according to the results of a study presented at the 54th Annual European Society for Pediatric Endocrinology Meeting in Barcelona.
The budget is not realistic, counting on fantastical revenue projections as well as a redevelopment gambit that's likely to be blocked in court. It makes deep cuts in state programs that will have unwelcome repercussions in years to come. And if the revenue projections prove to be as overly optimistic as they seem, there will be more damaging cuts to education, child care and health services. Nevertheless, it's a more earnest effort to clean up the state's budget mess than Sacramento has seen in a decade or more.
After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.
› Verified 8 days ago
| Entity Name | Saint Joseph Mercy Livingston Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285753236 PECOS PAC ID: 8628964525 Enrollment ID: O20040301000934 |
News Archive
QRxPharma Limited announced today the United States Food and Drug Administration has scheduled a meeting on 3 October to discuss the Company's MOXDUO New Drug Application for the treatment of moderate to severe acute pain.
Can estrogen preserve brain function and decrease the risk of Alzheimer's disease when given early in menopause? Newly postmenopausal women who received estrogen via a skin patch had reduced beta-amyloid deposits, the sticky plaques found in the brains of people with Alzheimer's disease, a Mayo Clinic study published this month in the Journal of Alzheimer's Disease found.
Taller individuals are more likely to develop cancer than shorter people, according to the results of a study presented at the 54th Annual European Society for Pediatric Endocrinology Meeting in Barcelona.
The budget is not realistic, counting on fantastical revenue projections as well as a redevelopment gambit that's likely to be blocked in court. It makes deep cuts in state programs that will have unwelcome repercussions in years to come. And if the revenue projections prove to be as overly optimistic as they seem, there will be more damaging cuts to education, child care and health services. Nevertheless, it's a more earnest effort to clean up the state's budget mess than Sacramento has seen in a decade or more.
After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.
› Verified 8 days ago
| Entity Name | Hospitalist Physicians Medical Group Of Michigan, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003978867 PECOS PAC ID: 4688778228 Enrollment ID: O20070409000434 |
News Archive
QRxPharma Limited announced today the United States Food and Drug Administration has scheduled a meeting on 3 October to discuss the Company's MOXDUO New Drug Application for the treatment of moderate to severe acute pain.
Can estrogen preserve brain function and decrease the risk of Alzheimer's disease when given early in menopause? Newly postmenopausal women who received estrogen via a skin patch had reduced beta-amyloid deposits, the sticky plaques found in the brains of people with Alzheimer's disease, a Mayo Clinic study published this month in the Journal of Alzheimer's Disease found.
Taller individuals are more likely to develop cancer than shorter people, according to the results of a study presented at the 54th Annual European Society for Pediatric Endocrinology Meeting in Barcelona.
The budget is not realistic, counting on fantastical revenue projections as well as a redevelopment gambit that's likely to be blocked in court. It makes deep cuts in state programs that will have unwelcome repercussions in years to come. And if the revenue projections prove to be as overly optimistic as they seem, there will be more damaging cuts to education, child care and health services. Nevertheless, it's a more earnest effort to clean up the state's budget mess than Sacramento has seen in a decade or more.
After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert M Fields, DO 2000 Green Rd, Suite 300, Ann Arbor, MI 48105-1598 Ph: (734) 995-3764 | Robert M Fields, DO 5301 Mcauley Dr, Ypsilanti, MI 48197-1051 Ph: (734) 712-3456 |
News Archive
QRxPharma Limited announced today the United States Food and Drug Administration has scheduled a meeting on 3 October to discuss the Company's MOXDUO New Drug Application for the treatment of moderate to severe acute pain.
Can estrogen preserve brain function and decrease the risk of Alzheimer's disease when given early in menopause? Newly postmenopausal women who received estrogen via a skin patch had reduced beta-amyloid deposits, the sticky plaques found in the brains of people with Alzheimer's disease, a Mayo Clinic study published this month in the Journal of Alzheimer's Disease found.
Taller individuals are more likely to develop cancer than shorter people, according to the results of a study presented at the 54th Annual European Society for Pediatric Endocrinology Meeting in Barcelona.
The budget is not realistic, counting on fantastical revenue projections as well as a redevelopment gambit that's likely to be blocked in court. It makes deep cuts in state programs that will have unwelcome repercussions in years to come. And if the revenue projections prove to be as overly optimistic as they seem, there will be more damaging cuts to education, child care and health services. Nevertheless, it's a more earnest effort to clean up the state's budget mess than Sacramento has seen in a decade or more.
After recent consultation with the FDA in November 2010, Merrion is preparing for its Phase III study for Orazol. If successful, the Phase III study will allow a new drug application for Orazol to be made under the FDA's abbreviated approval procedure section 505(b)(2) using a single Phase III study. The study will compare Orazol against placebo as an adjuvant breast cancer treatment with a primary endpoint of Disease Free Survival of patients with breast cancer.
› Verified 8 days ago
Charmaine R Gregory, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5301 Mcauley Dr, Ypsilanti, MI 48197 Phone: 734-712-3456 | |
Dr. Tanya Boldenow, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-3935 | |
Dr. Monique Reeves, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 555 Towner St, Ypsilanti, MI 48198 Phone: 734-544-6869 Fax: 734-544-6704 | |
Kim Marie Smith, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5301 Mcauley Dr, Ypsilanti, MI 48197 Phone: 734-712-3456 | |
Dr. Lee Benjamin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-3962 | |
Sara Barnes, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5301 Mcauley Dr, Ypsilanti, MI 48197 Phone: 734-712-3456 |